Global Candidiasis Therapeutics Market Professional Survey Report 2017

Publisher Name :
Date: 08-Dec-2017
No. of pages: 114
Inquire Before Buying

This report studies Candidiasis Therapeutics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

- Novartis AG

- Amgen

- F. Hoffmann-La Roche Ltd.

- Bayer-Algeta

- Merrion Pharmaceuticals Plc.

- Ablynx

- Genta Incorporated

- Galapagos NV

- Catena Pharmaceuticals Inc.

- Digna Biotech S.L.

- Medivir AB

- Amura Holdings

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Doxorubicin

- Cisplatin

- 7Carboplatin

- Etoposide

- Ifosfamide

- Cyclophosphamide

- Methotrexate

- Vincristine

By Application, the market can be split into

- Multispecialty Hospitals

- Cancer Research Institutes

- Others

By Regions, this report covers (we can add the regions/countries as you want)

- North America

- China

- Europe

- Southeast Asia

- Japan

- India

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Candidiasis Therapeutics Market Professional Survey Report 2017

Table of Contents
Global Candidiasis Therapeutics Market Professional Survey Report 2017
1 Industry Overview of Candidiasis Therapeutics
1.1 Definition and Specifications of Candidiasis Therapeutics
1.1.1 Definition of Candidiasis Therapeutics
1.1.2 Specifications of Candidiasis Therapeutics
1.2 Classification of Candidiasis Therapeutics
1.2.1 Doxorubicin
1.2.2 Cisplatin
1.2.3 7Carboplatin
1.2.4 Etoposide
1.2.5 Ifosfamide
1.2.6 Cyclophosphamide
1.2.7 Methotrexate
1.2.8 Vincristine
1.3 Applications of Candidiasis Therapeutics
1.3.1 Multispecialty Hospitals
1.3.2 Cancer Research Institutes
1.3.3 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 Manufacturing Cost Structure Analysis of Candidiasis Therapeutics
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Candidiasis Therapeutics
2.3 Manufacturing Process Analysis of Candidiasis Therapeutics
2.4 Industry Chain Structure of Candidiasis Therapeutics
3 Technical Data and Manufacturing Plants Analysis of Candidiasis Therapeutics
3.1 Capacity and Commercial Production Date of Global Candidiasis Therapeutics Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Candidiasis Therapeutics Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Candidiasis Therapeutics Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Candidiasis Therapeutics Major Manufacturers in 2016
4 Global Candidiasis Therapeutics Overall Market Overview
4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017E Global Candidiasis Therapeutics Capacity and Growth Rate Analysis
4.2.2 2016 Candidiasis Therapeutics Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017E Global Candidiasis Therapeutics Sales and Growth Rate Analysis
4.3.2 2016 Candidiasis Therapeutics Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017E Global Candidiasis Therapeutics Sales Price
4.4.2 2016 Candidiasis Therapeutics Sales Price Analysis (Company Segment)
5 Candidiasis Therapeutics Regional Market Analysis
5.1 North America Candidiasis Therapeutics Market Analysis
5.1.1 North America Candidiasis Therapeutics Market Overview
5.1.2 North America 2012-2017E Candidiasis Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2012-2017E Candidiasis Therapeutics Sales Price Analysis
5.1.4 North America 2016 Candidiasis Therapeutics Market Share Analysis
5.2 China Candidiasis Therapeutics Market Analysis
5.2.1 China Candidiasis Therapeutics Market Overview
5.2.2 China 2012-2017E Candidiasis Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2012-2017E Candidiasis Therapeutics Sales Price Analysis
5.2.4 China 2016 Candidiasis Therapeutics Market Share Analysis
5.3 Europe Candidiasis Therapeutics Market Analysis
5.3.1 Europe Candidiasis Therapeutics Market Overview
5.3.2 Europe 2012-2017E Candidiasis Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2012-2017E Candidiasis Therapeutics Sales Price Analysis
5.3.4 Europe 2016 Candidiasis Therapeutics Market Share Analysis
5.4 Southeast Asia Candidiasis Therapeutics Market Analysis
5.4.1 Southeast Asia Candidiasis Therapeutics Market Overview
5.4.2 Southeast Asia 2012-2017E Candidiasis Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2012-2017E Candidiasis Therapeutics Sales Price Analysis
5.4.4 Southeast Asia 2016 Candidiasis Therapeutics Market Share Analysis
5.5 Japan Candidiasis Therapeutics Market Analysis
5.5.1 Japan Candidiasis Therapeutics Market Overview
5.5.2 Japan 2012-2017E Candidiasis Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2012-2017E Candidiasis Therapeutics Sales Price Analysis
5.5.4 Japan 2016 Candidiasis Therapeutics Market Share Analysis
5.6 India Candidiasis Therapeutics Market Analysis
5.6.1 India Candidiasis Therapeutics Market Overview
5.6.2 India 2012-2017E Candidiasis Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2012-2017E Candidiasis Therapeutics Sales Price Analysis
5.6.4 India 2016 Candidiasis Therapeutics Market Share Analysis
6 Global 2012-2017E Candidiasis Therapeutics Segment Market Analysis (by Type)
6.1 Global 2012-2017E Candidiasis Therapeutics Sales by Type
6.2 Different Types of Candidiasis Therapeutics Product Interview Price Analysis
6.3 Different Types of Candidiasis Therapeutics Product Driving Factors Analysis
6.3.1 Doxorubicin of Candidiasis Therapeutics Growth Driving Factor Analysis
6.3.2 Cisplatin of Candidiasis Therapeutics Growth Driving Factor Analysis
6.3.3 7Carboplatin of Candidiasis Therapeutics Growth Driving Factor Analysis
6.3.4 Etoposide of Candidiasis Therapeutics Growth Driving Factor Analysis
6.3.5 Ifosfamide of Candidiasis Therapeutics Growth Driving Factor Analysis
6.3.6 Cyclophosphamide of Candidiasis Therapeutics Growth Driving Factor Analysis
6.3.7 Methotrexate of Candidiasis Therapeutics Growth Driving Factor Analysis
6.3.8 Vincristine of Candidiasis Therapeutics Growth Driving Factor Analysis
7 Global 2012-2017E Candidiasis Therapeutics Segment Market Analysis (by Application)
7.1 Global 2012-2017E Candidiasis Therapeutics Consumption by Application
7.2 Different Application of Candidiasis Therapeutics Product Interview Price Analysis
7.3 Different Application of Candidiasis Therapeutics Product Driving Factors Analysis
7.3.1 Multispecialty Hospitals of Candidiasis Therapeutics Growth Driving Factor Analysis
7.3.2 Cancer Research Institutes of Candidiasis Therapeutics Growth Driving Factor Analysis
7.3.3 Others of Candidiasis Therapeutics Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Candidiasis Therapeutics
8.1 Novartis AG
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Novartis AG 2016 Candidiasis Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Novartis AG 2016 Candidiasis Therapeutics Business Region Distribution Analysis
8.2 Amgen
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Amgen 2016 Candidiasis Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Amgen 2016 Candidiasis Therapeutics Business Region Distribution Analysis
8.3 F. Hoffmann-La Roche Ltd.
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 F. Hoffmann-La Roche Ltd. 2016 Candidiasis Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 F. Hoffmann-La Roche Ltd. 2016 Candidiasis Therapeutics Business Region Distribution Analysis
8.4 Bayer-Algeta
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Bayer-Algeta 2016 Candidiasis Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Bayer-Algeta 2016 Candidiasis Therapeutics Business Region Distribution Analysis
8.5 Merrion Pharmaceuticals Plc.
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Merrion Pharmaceuticals Plc. 2016 Candidiasis Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Merrion Pharmaceuticals Plc. 2016 Candidiasis Therapeutics Business Region Distribution Analysis
8.6 Ablynx
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Ablynx 2016 Candidiasis Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Ablynx 2016 Candidiasis Therapeutics Business Region Distribution Analysis
8.7 Genta Incorporated
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Genta Incorporated 2016 Candidiasis Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Genta Incorporated 2016 Candidiasis Therapeutics Business Region Distribution Analysis
8.8 Galapagos NV
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Galapagos NV 2016 Candidiasis Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Galapagos NV 2016 Candidiasis Therapeutics Business Region Distribution Analysis
8.9 Catena Pharmaceuticals Inc.
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Catena Pharmaceuticals Inc. 2016 Candidiasis Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Catena Pharmaceuticals Inc. 2016 Candidiasis Therapeutics Business Region Distribution Analysis
8.10 Digna Biotech S.L.
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Digna Biotech S.L. 2016 Candidiasis Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Digna Biotech S.L. 2016 Candidiasis Therapeutics Business Region Distribution Analysis
8.11 Medivir AB
8.12 Amura Holdings
9 Development Trend of Analysis of Candidiasis Therapeutics Market
9.1 Global Candidiasis Therapeutics Market Trend Analysis
9.1.1 Global 2017-2022 Candidiasis Therapeutics Market Size (Volume and Value) Forecast
9.1.2 Global 2017-2022 Candidiasis Therapeutics Sales Price Forecast
9.2 Candidiasis Therapeutics Regional Market Trend
9.2.1 North America 2017-2022 Candidiasis Therapeutics Consumption Forecast
9.2.2 China 2017-2022 Candidiasis Therapeutics Consumption Forecast
9.2.3 Europe 2017-2022 Candidiasis Therapeutics Consumption Forecast
9.2.4 Southeast Asia 2017-2022 Candidiasis Therapeutics Consumption Forecast
9.2.5 Japan 2017-2022 Candidiasis Therapeutics Consumption Forecast
9.2.6 India 2017-2022 Candidiasis Therapeutics Consumption Forecast
9.3 Candidiasis Therapeutics Market Trend (Product Type)
9.4 Candidiasis Therapeutics Market Trend (Application)
10 Candidiasis Therapeutics Marketing Type Analysis
10.1 Candidiasis Therapeutics Regional Marketing Type Analysis
10.2 Candidiasis Therapeutics International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Candidiasis Therapeutics by Region
10.4 Candidiasis Therapeutics Supply Chain Analysis
11 Consumers Analysis of Candidiasis Therapeutics
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 Conclusion of the Global Candidiasis Therapeutics Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Candidiasis Therapeutics
Table Product Specifications of Candidiasis Therapeutics
Table Classification of Candidiasis Therapeutics
Figure Global Production Market Share of Candidiasis Therapeutics by Type in 2016
Figure Doxorubicin Picture
Table Major Manufacturers of Doxorubicin
Figure Cisplatin Picture
Table Major Manufacturers of Cisplatin
Figure 7Carboplatin Picture
Table Major Manufacturers of 7Carboplatin
Figure Etoposide Picture
Table Major Manufacturers of Etoposide
Figure Ifosfamide Picture
Table Major Manufacturers of Ifosfamide
Figure Cyclophosphamide Picture
Table Major Manufacturers of Cyclophosphamide
Figure Methotrexate Picture
Table Major Manufacturers of Methotrexate
Figure Vincristine Picture
Table Major Manufacturers of Vincristine
Table Applications of Candidiasis Therapeutics
Figure Global Consumption Volume Market Share of Candidiasis Therapeutics by Application in 2016
Figure Multispecialty Hospitals Examples
Table Major Consumers in Multispecialty Hospitals
Figure Cancer Research Institutes Examples
Table Major Consumers in Cancer Research Institutes
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Candidiasis Therapeutics by Regions
Figure North America Candidiasis Therapeutics Market Size (Million USD) (2012-2022)
Figure China Candidiasis Therapeutics Market Size (Million USD) (2012-2022)
Figure Europe Candidiasis Therapeutics Market Size (Million USD) (2012-2022)
Figure Southeast Asia Candidiasis Therapeutics Market Size (Million USD) (2012-2022)
Figure Japan Candidiasis Therapeutics Market Size (Million USD) (2012-2022)
Figure India Candidiasis Therapeutics Market Size (Million USD) (2012-2022)
Table Candidiasis Therapeutics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Candidiasis Therapeutics in 2016
Figure Manufacturing Process Analysis of Candidiasis Therapeutics
Figure Industry Chain Structure of Candidiasis Therapeutics
Table Capacity and Commercial Production Date of Global Candidiasis Therapeutics Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Candidiasis Therapeutics Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Candidiasis Therapeutics Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Candidiasis Therapeutics Major Manufacturers in 2016
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Candidiasis Therapeutics 2012-2017
Figure Global 2012-2017E Candidiasis Therapeutics Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Candidiasis Therapeutics Market Size (Value) and Growth Rate
Table 2012-2017E Global Candidiasis Therapeutics Capacity and Growth Rate
Table 2016 Global Candidiasis Therapeutics Capacity (K Pcs) List (Company Segment)
Table 2012-2017E Global Candidiasis Therapeutics Sales (K Pcs) and Growth Rate
Table 2016 Global Candidiasis Therapeutics Sales (K Pcs) List (Company Segment)
Table 2012-2017E Global Candidiasis Therapeutics Sales Price (USD/Pcs)
Table 2016 Global Candidiasis Therapeutics Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of Candidiasis Therapeutics 2012-2017E
Figure North America 2012-2017E Candidiasis Therapeutics Sales Price (USD/Pcs)
Figure North America 2016 Candidiasis Therapeutics Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of Candidiasis Therapeutics 2012-2017E
Figure China 2012-2017E Candidiasis Therapeutics Sales Price (USD/Pcs)
Figure China 2016 Candidiasis Therapeutics Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of Candidiasis Therapeutics 2012-2017E
Figure Europe 2012-2017E Candidiasis Therapeutics Sales Price (USD/Pcs)
Figure Europe 2016 Candidiasis Therapeutics Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Candidiasis Therapeutics 2012-2017E
Figure Southeast Asia 2012-2017E Candidiasis Therapeutics Sales Price (USD/Pcs)
Figure Southeast Asia 2016 Candidiasis Therapeutics Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of Candidiasis Therapeutics 2012-2017E
Figure Japan 2012-2017E Candidiasis Therapeutics Sales Price (USD/Pcs)
Figure Japan 2016 Candidiasis Therapeutics Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of Candidiasis Therapeutics 2012-2017E
Figure India 2012-2017E Candidiasis Therapeutics Sales Price (USD/Pcs)
Figure India 2016 Candidiasis Therapeutics Sales Market Share
Table Global 2012-2017E Candidiasis Therapeutics Sales (K Pcs) by Type
Table Different Types Candidiasis Therapeutics Product Interview Price
Table Global 2012-2017E Candidiasis Therapeutics Sales (K Pcs) by Application
Table Different Application Candidiasis Therapeutics Product Interview Price
Table Novartis AG Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novartis AG Candidiasis Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Novartis AG Candidiasis Therapeutics Business Region Distribution
Table Amgen Information List
Table Product A Overview
Table Product B Overview
Table 2016 Amgen Candidiasis Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Amgen Candidiasis Therapeutics Business Region Distribution
Table F. Hoffmann-La Roche Ltd. Information List
Table Product A Overview
Table Product B Overview
Table 2015 F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Business Region Distribution
Table Bayer-Algeta Information List
Table Product A Overview
Table Product B Overview
Table 2016 Bayer-Algeta Candidiasis Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Bayer-Algeta Candidiasis Therapeutics Business Region Distribution
Table Merrion Pharmaceuticals Plc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Business Region Distribution
Table Ablynx Information List
Table Product A Overview
Table Product B Overview
Table 2016 Ablynx Candidiasis Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Ablynx Candidiasis Therapeutics Business Region Distribution
Table Genta Incorporated Information List
Table Product A Overview
Table Product B Overview
Table 2016 Genta Incorporated Candidiasis Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Genta Incorporated Candidiasis Therapeutics Business Region Distribution
Table Galapagos NV Information List
Table Product A Overview
Table Product B Overview
Table 2016 Galapagos NV Candidiasis Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Galapagos NV Candidiasis Therapeutics Business Region Distribution
Table Catena Pharmaceuticals Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Catena Pharmaceuticals Inc. Candidiasis Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Catena Pharmaceuticals Inc. Candidiasis Therapeutics Business Region Distribution
Table Digna Biotech S.L. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Digna Biotech S.L. Candidiasis Therapeutics Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Digna Biotech S.L. Candidiasis Therapeutics Business Region Distribution
Table Medivir AB Information List
Table Amura Holdings Information List
Figure Global 2017-2022 Candidiasis Therapeutics Market Size (K Pcs) and Growth Rate Forecast
Figure Global 2017-2022 Candidiasis Therapeutics Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Candidiasis Therapeutics Sales Price (USD/Pcs) Forecast
Figure North America 2017-2022 Candidiasis Therapeutics Consumption Volume (K Pcs) and Growth Rate Forecast
Figure China 2017-2022 Candidiasis Therapeutics Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Europe 2017-2022 Candidiasis Therapeutics Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Candidiasis Therapeutics Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Japan 2017-2022 Candidiasis Therapeutics Consumption Volume (K Pcs) and Growth Rate Forecast
Figure India 2017-2022 Candidiasis Therapeutics Consumption Volume (K Pcs) and Growth Rate Forecast
Table Global Sales Volume (K Pcs) of Candidiasis Therapeutics by Type 2017-2022
Table Global Consumption Volume (K Pcs) of Candidiasis Therapeutics by Application 2017-2022
Table Traders or Distributors with Contact Information of Candidiasis Therapeutics by Region
  • Global Calming and Sleeping Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 17-Oct-2018        Price: US 3480 Onwards        Pages: 132
    Calming and sleeping products reduce tension and anxiety by inducing sedatives and a hypnotic effect on the body. They act by depressing the central nervous system. Scope of the Report: This report focuses on the Calming and Sleeping in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. They are used to tr......
  • Global Glycinates Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 17-Oct-2018        Price: US 3480 Onwards        Pages: 137
    Glycine is an amino acid of endogenous antioxidant reductive glutathione. It is often added exogenously in severe stress, sometimes called semi-essential amino acid. Scope of the Report: This report focuses on the Glycinates in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The feed additive segment is ......
  • Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 35
    Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline Review, H2 2018 Summary Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Aurora Kinase C is a member of the Aurora sub......
  • Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Beta or PIK3CB or EC 2.7.1.153) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 74
    Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Beta or PIK3CB or EC 2.7.1.153) - Pipeline Review, H2 2018 Summary Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Beta or PIK3CB or EC 2.7.1.153) pipeline Target constitutes close to 15 molecules. Out of which app......
  • Transforming Growth Factor Beta 2 (BSC1 Cell Growth Inhibitor or Cetermin or Glioblastoma Derived T Cell Suppressor Factor or Polyergin or TGFB2) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 50
    Transforming Growth Factor Beta 2 (BSC1 Cell Growth Inhibitor or Cetermin or Glioblastoma Derived T Cell Suppressor Factor or Polyergin or TGFB2) - Pipeline Review, H2 2018 Summary Transforming Growth Factor Beta 2 (BSC1 Cell Growth Inhibitor or Cetermin or Glioblastoma Derived T Cell Suppressor Factor or Polyergin or TGFB2) - Transforming growth factor beta 2 (TGF-ß2) is a polypeptide member of the transforming growth factor beta superfamily of cytokines encoded by......
  • Transforming Growth Factor Beta 1 (TGFB1) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 73
    Transforming Growth Factor Beta 1 (TGFB1) - Pipeline Review, H2 2018 Summary Transforming Growth Factor Beta 1 (TGFB1) pipeline Target constitutes close to 22 molecules. Out of which approximately 15 molecules are developed by companies and remaining by the universities/institutes. The latest report Transforming Growth Factor Beta 1- Pipeline Review, H2 2018, outlays comprehensive information on the Transforming Growth Factor Beta 1 (TGFB1) targeted therapeutics, co......
  • Beta Secretase 1 (Aspartyl Protease 2 or Beta Site Amyloid Precursor Protein Cleaving Enzyme 1 or Memapsin 2 or Membrane Associated Aspartic Protease 2 or BACE1 or EC 3.4.23.46) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 69
    Beta Secretase 1 (Aspartyl Protease 2 or Beta Site Amyloid Precursor Protein Cleaving Enzyme 1 or Memapsin 2 or Membrane Associated Aspartic Protease 2 or BACE1 or EC 3.4.23.46) - Pipeline Review, H2 2018 Summary Beta Secretase 1 (Aspartyl Protease 2 or Beta Site Amyloid Precursor Protein Cleaving Enzyme 1 or Memapsin 2 or Membrane Associated Aspartic Protease 2 or BACE1 or EC 3.4.23.46) - Beta-secretase 1 (BACE1) is an enzyme that in humans is encoded by the BACE1 ......
  • Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 73
    Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Review, H2 2018 Summary According to the recently published report 'Lysosomal Alpha Glucosidase - Pipeline Review, H2 2018'; Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) pipeline Target constitutes close to 16 molecules. Out of which approximately 13 molecules are developed by companies and remaining by the universities/institutes......
  • Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 56
    Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2018 Summary Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) pipeline Target constitutes close to 17 molecules. Out of which approximately 12 molecules are developed by companies and remaining by the universities/institutes. The latest report Glycogen Synthase Kinase 3 Be......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs